Edition:
United Kingdom

Idorsia Ltd (IDIA.S)

IDIA.S on Swiss Exchange

23.52CHF
19 Jul 2019
Change (% chg)

CHF0.40 (+1.73%)
Prev Close
CHF23.12
Open
CHF23.30
Day's High
CHF23.70
Day's Low
CHF23.22
Volume
270,994
Avg. Vol
294,831
52-wk High
CHF26.00
52-wk Low
CHF15.20

Select another date:

Thu, Apr 18 2019

UPDATE 1-Idorsia confirms 2019 spending plan as clinical trials "on track"

ZURICH, April 18 Swiss biotech Idorsia said on Thursday that all four clinical trials of its late-stage drug hopefuls were "on track" as it confirmed expectations of spending 570 million Swiss francs ($564 million) in the current year on the projects.

BRIEF-Idorsia Q1 US GAAP Net Loss Widens To CHF 106 Mln

* IDORSIA ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER 2019

UPDATE 2-Swiss Idorsia says 'stay tuned' for deals as it manages pipeline

* CFO says J&J was fully aware of Actelion DOJ probe (Adds details about possible deals, comments from CEO, CFO, details about Actelion settlement)

BRIEF-Idorsia: First Patient Recruited Into React - Phase 3 Registration Study With Clazosentan

* ANNOUNCES FIRST PATIENT RECRUITED INTO REACT - PHASE 3 REGISTRATION STUDY WITH CLAZOSENTAN Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Select another date: